Comparative Pharmacology
Head-to-head clinical analysis: SEASONALE versus SELFEMRA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SEASONALE versus SELFEMRA.
SEASONALE vs SELFEMRA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Seasonale is a combination oral contraceptive containing ethinyl estradiol and levonorgestrel. It suppresses gonadotropin release, inhibiting ovulation, and alters cervical mucus to reduce sperm penetration and endometrial lining to reduce implantation.
Selective estrogen receptor degrader (SERD) that binds to estrogen receptor alpha (ERα), inducing its degradation and inhibiting estrogen-dependent cell proliferation.
One tablet (0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel) orally once daily for 84 consecutive days, followed by 7 days of placebo.
1 tablet (50 mg) orally once daily with food.
None Documented
None Documented
Ethinyl estradiol: terminal half-life 13-27 hours (mean 17 hours); levonorgestrel: terminal half-life 11-45 hours (mean 25 hours). Clinical context: Supports once-daily dosing; steady-state achieved within 5-10 days.
Terminal elimination half-life of 12-16 hours in healthy adults; prolonged to 24-36 hours in severe renal impairment (CrCl <30 mL/min).
Renal excretion of metabolites (approximately 50-60% as glucuronide and sulfate conjugates of ethinyl estradiol and levonorgestrel) and fecal elimination (approximately 40-50%).
Primarily renal excretion as unchanged drug (50-60%) and metabolites (20-30%); biliary/fecal elimination accounts for 10-15%.
Category C
Category C
Contraceptive, Combination Hormonal
Contraceptive, Combination Hormonal